Abstract
Purpose
This study tested the possibility of localized intravascular infusion of positive charged paclitaxel-loaded nanoparticles (NPs) to better prevent neointimal formation in a rabbit carotid artery injury model.
Materials and Methods
NPs were prepared by oil–water emulsion/solvent evaporation technique using biodegradable poly (lactide-co-glycolide) (PLGA). A cationic surfactant, didodecyldimethylammonium bromide (DMAB), was absorbed on the NP surface by electrostatic attraction between positive and negative charges. NPs were characterized in such aspects as size, surface morphology, surface charges as well as in vitro drug release profile. Balloon injured rabbit carotid arteries were treated with single infusion of paclitaxel-loaded NP suspension and observed for 28 days. The inhibitory effects of NPs on neointima formation were evaluated as end-point.
Results
NPs showed spherical shape with a diameter ranging from 200 to 500 nm. Negatively charged PLGA NPs shifted to positive after the DMAB modification. The in vitro drug release profile showed a biphasic release pattern. Morphometric analyses on the retrieved artery samples revealed that the inhibitory effect of intima proliferation was dose-dependent. At a concentration of 30 mg ml−1, NP infusion completely inhibited intima proliferation in a rabbit vascular injury model.
Conclusions
Paclitaxel-loaded NPs with DMAB modification were proven an effective means of inhibiting proliferative response to vascular injury in a rabbit model.
Abbreviations
- CCA:
-
common carotid artery
- DCM:
-
dichloromethane
- DES:
-
drug-eluting stent
- DMAB:
-
didodecyldimethylammonium bromide
- EE:
-
entrapment efficiency
- HE:
-
hematoxylin & eosin
- HPLC:
-
high performance liquid chromatography
- NP:
-
nanoparticle
- PLGA:
-
Poly(dl-lactide-co-glycolide)
- PVA:
-
polyvinyl alcohol
- SEM:
-
scanning electron microscopy
- TEM:
-
transmission electronic microscopy
- VSMC:
-
vascular smooth muscle cell
References
J. A. Bittl. Advances in coronary angioplasty. N. Engl. J. Med. 335:1290–1302 (1996).
U. Westedt, L. Barbu-Tudoran, A. K. Schaper, M. Kalinowsk, H. Alfke, and T. Kissel. Deposition of nanoparticles in the arterial vessel by porous balloon catheters: localization by confocal laser scanning microscopy and transmission electron microscopy. AAPS PharmSci in vitro(4):1–6 (2004).
G. S. Mintz, J. J. Popma, A. D. Pichard, K. M. Kent, L. F. Satler, C. Wong, M. K. Hong, J. A. Kovach, and M. B. Leon. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 94(1):35–43 (1996).
T. Kimura, S. Kaburagi, T. Tamura, H. Yokoi, Y. Nakagawa, H. Yokoi, N Hamasaki, H. Nosaka, M. Nobuyoshi, G. S. Mintz, J. J. Popma, and M. B. Leon. Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy. Circulation 96(2):475–483 (1997).
H. Hanke, T. Strohschneider, M. Oberhoff, E. Betz, and K. R. Karsch. Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ. Res. 67(3):651–659 (1990).
Y. Shi, J. E. O’Brien, L. Ala-Kokko, W. Chung, J. D. Mannion, and A. Zalewski. Origin of extracellular matrix synthesis during coronary repair. Circulation 95(4):997–1006 (1997).
C. Hehrlein, C. Gollan, K. Donges, J. Metz, R. Riessen, P. Fehsenfeld, E. von Hodenberg, and W. Kubler. Low -dose radioactive endovascular stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. Circulation 92(6):1570–1575 (1995).
E. Regar, G. Sianos, and P. W. Serruys. Stent development and local drug delivery. Br. Med. Bull. 59(1):227–248 (2001).
E. Grube, S. Silber, K. E. Hauptmann, R. Mueller, L. Buellesfeld, U. Gerckens, and M. E. Russell. TAXUS I: six- and 12-month results from a randomized, double-blind trial on a slow-release paclitaxeleluting stent for de novo coronary lesions. Circulation 107:38–42 (2003).
S. J. Park, W. H. Shim, D. S. Ho, A. E. Raizner, S. W. Park, M. K. Hong, C. W. Lee, D. Choi, Y. Jang, R. Lam, N. J. Weissman, and G. S. Mintz. A paclitaxel-eluting stent for the prevention of coronary restenosis. N. Engl. J. Med. 348:1537–1545 (2003).
J. W. Moses, M. B. Leon, J. J. Popma, P. J. Fitzgerald, D. R. Holmes, C. O’Shaughnessy, R. P. Caputo, D. J. Kereiakes, D. O. Williams, P. S. Teirstein, J. L. Jaeger, and R. E. Kuntz. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N. Engl. J. Med. 349:1315–1323 (2003).
S. Banai, M. Chorny, S. D. Gertz, I. Fishbein, J. Gao, L. Perez, G. Lazarovichi, A. Gazit, A. Levitzki, and G. Golomb. Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries. Biomaterials 26:4898–4901 (2005).
H. Wolinsky and S. N. Thung. Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J. Am. Coll. Cardiol. 15(2):475–481 (1990).
B. Scheller, U. Speck, C. Abramjuk, U. Bernhardt, M. Böhm, and G. Nickenig. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110(7):810–814 (2004).
D. W. Muller, E. J. Topol, G. D. Abrams, K. P. Gallagher, and S. G. Ellis. Intramural methotrexate therapy for the prevention of neointimal thickening after balloon angioplasty. J. Am. Coll. Cardiol. 20(2):460–466 (1992).
T. L. Lambert, V. Dev, E. Rechavia, J. S. Forrester, F. Litvack, and N. L. Eigler. Localized arterial wall drug delivery from a polymer-coated removable metallic stent: kinetics, distribution, and bioactivity of forskolin. Circulation 90(2):1003–1011 (1994).
F. Valero, M. Hamon, C. Fournier, T. Meurice, B. Flautre, E. Van Belle, J. M. Lablanche, B. Gosselin, C. Bauters, and M. Bertrand. Intramural injection of biodegradable microspheres as a local drug-delivery system to inhibit neointimal thickening in a rabbit model of balloon angioplasty. J. Cardiovasc. Pharmacol. 31(4):513–519 (1998).
R. L. Wilensky, K. L. March, I. Gradus-Pizlo, D. Schauwecker, M. B. Michaels, J. Robinson, K. Carlson, and D. R. Hathaway. Regional and arterial localization of radioactive microparticles after local delivery by unsupported or supported porous balloon catheters. Am. Heart J. 129(5):852–859 (1995).
L. A. Guzman, V. Labhasetwar, C. Song, Y. Jang, A. M. Lincoff, R. Levy, and E. J. Topol. Local intraluminal infusion of biodegradable polymeric nanoparticles: a novel approach for prolonged drug delivery after balloon angioplasty. Circulation 94:1441–1448 (1996).
C. X. Song, V. Labhasetwar, H. Murphy, X. Qu, W. R. Humphrey, R. J. Shebuski, and R. J. Levy. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J. Control. Release 43:197–212 (1997).
V. Labhasetwar, C. Song, and R. J. Levy. Nanoparticle drug delivery system for restenosis. Adv. Drug Deliv. Rev. 24:63–85 (1997).
W. R. Humphrey, L. A. Erickson, C. A. Simmons, J. L. Northrup, D. G. Wishka, J. Morris, V. Labhasetwar, C. Song, R. J. Levy, and R. J. Shebuski. The effect of intramural delivery of polymeric nanoparticles loaded with the anti-proliferative 2-aminochromone U-86983 on neointimal hyperplasia development in balloon-injured porcine coronary. Adv. Drug Deliv. Rev. 24:87–108 (1997).
C. Song, V. Labhasetwar, X. Cui, T. Underwood, and R. J. Levy. Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model. J. Control. Release 54(2):201–211 (1998).
V. Labhasetwar, C. Song, W. Humphrey, R. Shebuski, and R. J. Levy. Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J. Pharm. Sci. 87(10):1229–1234 (1998).
K. R. Kamath, J. J. Barry, and K. M. Miller. The Taxus™ drug-eluting stent: a new paradigm in controlled drug delivery. Adv. Drug Deliv. Rev. 58(3):412–436 (2006).
D. W. Kim, J. S. Kwon, Y. G. Kim, M. S. Kim, G. S. Lee, T. J. Youn, and M. C. Cho. Novel oral formulation of paclitaxel inhibits neointimal hyperplasia in a rat carotid artery injury model. Circulation 109:1558–1563 (2004).
T. K. Nasser, R. L. Wilensky, K. Mehdi, and K. L. March. Microparticle deposition in periarterial microvasculature and intramural dissections after porous balloon delivery into atherosclerotic vessels: quantitation and localization by confocal scanning laser microscopy. Am. Heart J. 131(5):892–898 (1996).
J. J. Rome, V. Shayani, M. Y. Flugelman, K. D. Newman, A. Farb, R. Virmani, and D. A. Dichek. Anatomic barriers influence the distribution of in vivo gene transfer into the arterial wall: modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Arterioscler. Thromb. 14:148–161 (1994).
J. M. Anderson and M. S. Shive. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28:5–24 (1997).
I. Gradus-Pizlo, R. L. Wilensky, K. L. March, N. Fineberg, M. Michaels, G. E. Sandusky, and D. R. Hathaway. Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery. J. Am. Coll. Cardiol. 26(6):1549–1557 (1995).
V. Dev, N. Eigler, M. C. Fishbein, Y. Tian, A. Hickey, E. Rechavia, J. S. Forrester, and F. Litvack. Sustained local drug delivery to the arterial wall via biodegradable microspheres. Catheter. Cardiovasc. Diagn. 41(3):324–332 (1997).
L. A. M. Rupert, D. Hoekstra, and B. F. N. Engberts. Fusogenic behavior of didodecyldimethylammonium bromide bilayer vesicles. J. Am. Chem. Soc. 107:2628–2631 (1985).
H. Suh, B. Jeong, R. Rathi, and S. W. Kim. Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethyleneoxide)-poly(lactide/glycolide) nanospheres. J. Biomed. Mater. Res. 42:331–338 (1998).
J. K. Jackson, K. C. Skinner, L. Burgess, T. Sun, W. L. Hunter, and H. M. Burt. Paclitaxel-loaded crosslinked hyaluronic acid films for the prevention of postsurgical adhesions. Pharm. Res. 19:411–417 (2002).
N. Kunou, Y. Ogura, M. Hashizoe, Y. Honda, S. H. Hyon, and Y. Ikada. Controlled intraocular delivery of ganciclovir with use of biodegradable scleral implant in rabbits. J. Control. Release 37:143–150 (1995).
C. G. Pitt, M. M. Gratzl, A. R. Jeffcoat, R. Zweidinger, and A. Schindler. Sustained drug delivery systems. II. Factors affecting release rates from poly(ɛ-caprolactone) and related biodegradable polymers. J. Pharm. Sci. 68:1534–1538 (1979).
M. S. Hora, R. K. Rana, J. H. Nunberg, T. R. Tice, R. M. Gilley, and M. E. Hudson. Release of human serum albumin from retinitis with intravitreal injection of liposome encapsulated poly(lactide-co-glycolide) microspheres. Pharm. Res. 7:1190–1194 (1990).
T. Yasukawa, H. Kimura, Y. Tabata, and Y. Ogura. Biodegradable scleral plugs for vitreoretinal drug delivery. Adv. Drug Deliv. Rev. 52:25–36 (2001).
J. Panyam, M. M. Dali, S. K. Sahoo, W. Ma, S. S. Chakravarthi, G. L. Amidon, R. J. Levy, and V. Labhasetwar. Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles. J. Control. Release 92:173–187 (2003).
L. Manil, J. Davin, C. Duchenne, C. Kubiak, J. Foidart, P. Couvreur, and P. Mahieu. Uptake of nanoparticles by rat glomerular mesangial cells in vivo and in vitro. Pharm. Res. 11:1160–1167 (1994).
J. J. Wright and L. Illum. Active targeting of microcapsules and microspheres to specific regions. In M. Donbrow (ed.), Microcapsules and Nanoparticles in Medicine and Pharmacy, CRC Press, Boca Raton, FL, 1992, pp. 282–293.
J. You, M. Kamihira, and S. Iijima. Surfactant-mediated gene transfer for animal cells. Cytotechnology 25:45–52 (1997).
Acknowledgments
The authors are grateful to the Tianjin Natural Science Foundation project (023801311) and the NSFC of China (50473059) for funding this work. We thank Yongzhe Che (Medical College of Nankai University) for his direction and efforts in animal tests.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Mei, L., Sun, H., Jin, X. et al. Modified Paclitaxel-loaded Nanoparticles for Inhibition of Hyperplasia in a Rabbit Arterial Balloon Injury Model. Pharm Res 24, 955–962 (2007). https://doi.org/10.1007/s11095-006-9214-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-9214-z